4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-396944
Director sold 13,679 shares at $57.09 ($780,935)
- Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Behbahani Ali · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 1 in the form | +30,000 | $14.00 | $420,000 | 30,316 | D |
| 2026-09-17 | Sale : show line 2 in the form | −13,679 | $57.09 | $780,935 | 16,637 | D |
| Open-market sales · 13,679 sh · avg $57.09 · $780,935 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −30,000 | 0 | D |
Loading xslF345X06/ownership.xml…